EC fines Teva €60.5m over pay-for-delay deal

27-11-2020

Sarah Morgan

EC fines Teva €60.5m over pay-for-delay deal

madamF / Shutterstock.com

The European Commission has fined Teva and its subsidiary Cephalon €60.5 million ($72 million) for agreeing to delay a cheaper generic version of sleep disorder drug modafinil.


European Commission, Teva, Cephalon, generics, pay-for-delay, competition law, patents, modafinil, fines

LSIPR